Every Form 4 that Varex Imaging Corporation (VREX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow VREX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VREX filings page.
Varex Imaging Corp (VREX) reported equity compensation activity for Chief Human Resources Officer Karen L. Aranki. On August 14, 2026, 3,974 Restricted Stock Units vested and were converted on a one-for-one basis into 3,974 shares of common stock. Of these shares, 1,145 were withheld at a price of $18.49 per share to satisfy tax withholding obligations arising from the vesting. After this vesting, Aranki holds 3,975 Restricted Stock Units scheduled to vest 50% on August 15, 2026 and 50% on August 15, 2028, with vested shares to be delivered upon vesting.
Varex Imaging Corp director Jay K. Kunkel sold shares in a routine open-market transaction. He sold 4,510 shares of common stock at a price of $11.14 per share. After this sale, he directly holds 23,450 shares, so he continues to maintain a significant equity stake in the company.
Varex Imaging Corp director Kathleen Bardwell reported an acquisition of deferred stock units. On 02/12/2026, she received 12,331 Deferred Stock Units at a price of $0 per unit, all held as direct beneficial ownership.
Each Deferred Stock Unit converts into one share of common stock. The units vest 100% on the earlier of the one-year anniversary of the grant date or the next annual stockholder meeting after the grant date. Vested shares will be delivered upon the earlier of the third anniversary of the grant date, a change in control, or the end of Bardwell’s service for any reason.
Varex Imaging Corp director Jay K. Kunkel received a grant of 12,331 Deferred Stock Units on February 12, 2026. The grant is recorded at a price of $0 per unit and is reported as directly owned.
Each Deferred Stock Unit converts into one share of Varex common stock. The units vest 100% on the earlier of one year from the grant date or the next annual stockholder meeting after the grant. Vested shares are delivered on the earlier of the third anniversary of the grant, a change in control, or Kunkel’s termination of service for any reason.
Varex Imaging Corp director Walter M. Rosebrough Jr. received a grant of 14,947 Deferred Stock Units on February 12, 2026. These units were awarded at a price of $0 as a form of equity compensation and are held as a derivative security.
Each Deferred Stock Unit converts into one share of Varex Imaging common stock. The units vest 100% on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders, and the underlying shares will be delivered on the earlier of the third anniversary of the grant, a change in control, or the director’s termination of service.
Varex Imaging Corp director Christine A. Tsingos received an equity grant of 12,331 deferred stock units on February 12, 2026. The units were awarded at a price of $0 and are held directly. Each deferred stock unit converts into one share of Varex common stock.
The deferred stock units vest 100% on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders after the grant. Vested shares will be delivered to the director on the earlier of the third anniversary of the grant date, a change in control, or her termination of service.
Varex Imaging Corp director Timothy E. Guertin reported an award of deferred stock units. On February 12, 2026, he acquired 12,331 Deferred Stock Units at a price of $0, all held directly.
Each unit converts into one share of common stock. The units vest 100% on the earlier of the one-year anniversary of the grant date or the next annual stockholders’ meeting. Vested shares will be delivered on the earlier of the third anniversary of the grant date, a change in control, or Guertin’s termination of service.
Varex Imaging Corp director Jocelyn D. Chertoff received an equity award in the form of deferred stock units. On 02/12/2026, she was granted 12,331 Deferred Stock Units at a price of $0. Each unit converts into one share of common stock.
The Deferred Stock Units vest 100% on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders after the grant. Vested shares will be delivered to her on the earlier of the third anniversary of the grant date, a change in control, or her termination of service.
Varex Imaging Corp director Jay K. Kunkel reported a routine equity award settlement. On February 9, 2026, he converted 8,483 Deferred Stock Units into 8,483 shares of common stock at a price of $0 per share, reflecting previously granted director compensation.
The Deferred Stock Units were granted on February 9, 2023, vested on February 8, 2024, and were delivered in common stock on the third anniversary of the grant date. Following this settlement, Kunkel directly holds 27,960 shares of Varex Imaging Corp common stock.
Varex Imaging Corp director Jocelyn D. Chertoff reported the conversion of 8,483 Deferred Stock Units into 8,483 shares of common stock on February 9, 2026, at an exercise price of $0 per unit.
The footnotes state these Deferred Stock Units were granted on February 9, 2023, vested on February 8, 2024, and were delivered in stock on the third anniversary of the grant date. Following this settlement, Chertoff directly holds 42,194 shares of Varex Imaging common stock and no remaining Deferred Stock Units from this grant.
Varex Imaging Corp director Walter M. Rosebrough Jr. reported the conversion of 10,339 Deferred Stock Units into an equal number of Varex common shares on February 9, 2026. These units were originally granted on February 9, 2023 and became deliverable on the third anniversary of the grant date.
After this settlement, Rosebrough directly beneficially owns 52,654 shares of common stock. The Form 4 shows a routine equity compensation event with no cash consideration, as both the derivative units and the resulting common shares are reported at a transaction price of $0 per share.
Varex Imaging director Timothy E. Guertin converted deferred stock units into common shares. On February 9, 2026, 8,483 Deferred Stock Units were exercised and delivered as 8,483 shares of Varex Imaging common stock, consistent with a one-for-one conversion ratio.
These Deferred Stock Units were originally granted on February 9, 2023, vested on February 8, 2024, and were settled in stock on the third anniversary of the grant date. After this transaction, Guertin directly holds 26,777 shares of Varex Imaging common stock.
Varex Imaging Corp. director Kathleen Bardwell reported the conversion of equity awards into common stock. On February 9, 2026, she converted 8,483 Deferred Stock Units into 8,483 shares of common stock at an exercise price of $0 per share.
The filing shows this equity award delivery increased her directly held common stock to 12,102 shares after the transaction. Each Deferred Stock Unit converts into one share of common stock, reflecting previously granted and vested director compensation rather than an open-market purchase or sale.
Varex Imaging Corp director Christine A. Tsingos reported the delivery of vested equity awards. On February 9, 2026, 8,483 Deferred Stock Units converted into an equal number of shares of Varex Imaging common stock at an exercise price of $0 per share.
These Deferred Stock Units were originally granted on February 9, 2023, vested on February 8, 2024, and were delivered in stock on the third anniversary of the grant date. After this transaction, Tsingos directly beneficially owns 42,655 shares of Varex Imaging common stock.
Varex Imaging Corp reported an equity award update for its Chief Financial Officer, Shubham Maheshwari, on a Form 4. On 12/15/2025, he was credited with 4,515 performance stock units (PSUs) tied to an award originally granted on December 10, 2023, and 5,520 PSUs tied to an award granted on December 10, 2024, both at an exercise price of $0.
Each PSU represents a contingent right to receive one share of Varex Imaging common stock, based on achieving specified performance criteria. The amounts reported reflect PSUs earned for fiscal year 2025 performance. After the completion of fiscal year 2026 and fiscal year 2027, the Compensation Committee will certify the final number of PSUs earned for the respective grants, and vesting will require that the CFO remains employed through the vesting dates.
Varex Imaging Corp reported an insider equity update for its SVP and GM, Detectors. On 12/15/2025, the executive had performance stock units (PSUs) credited based on fiscal year 2025 results from two previously granted PSU awards.
For a grant awarded on December 10, 2023, 2,565 PSUs were earned for fiscal 2025, and for a grant awarded on December 10, 2024, 3,134 PSUs were earned for the same fiscal year’s performance. Each PSU represents a contingent right to receive one share of Varex Imaging common stock. Final PSU totals for these grants will be certified after fiscal years 2026 and 2027 respectively, and vesting depends on the executive remaining employed through the vesting dates.
Varex Imaging Corp reported an insider equity award update for senior executive Mark S. Jonaitis, who serves as SVP and GM, X-Ray Sources. On December 15, 2025, he acquired performance stock units (PSUs) that each represent a contingent right to receive one share of Varex Imaging common stock, subject to meeting performance goals.
The filing shows 2,565 PSUs tied to an award granted on December 10, 2023 and 3,134 PSUs tied to an award granted on December 10, 2024. In each case, the number reported reflects PSUs earned for fiscal year 2025 based on achievement of specified performance criteria. Final PSU amounts for the 2023 grant will be certified after fiscal 2026, and for the 2024 grant after fiscal 2027, with vesting conditioned on Mr. Jonaitis remaining employed through the vesting dates.
Varex Imaging Corp's President and CEO, who is also a director, reported new performance-based stock unit awards tied to company results. On December 15, 2025, the insider acquired 15,394 performance stock units (PSUs) from a grant originally made on December 10, 2023, and 18,801 PSUs from a grant originally made on December 10, 2024. Each PSU represents the right to receive one share of Varex Imaging common stock if specific performance goals are met.
The PSUs earned for fiscal year 2025 reflect the achievement of performance criteria during that year. For the 2023 grant, the total PSUs earned will be certified after completion of fiscal year 2026, and for the 2024 grant after fiscal year 2027. In both cases, vesting also depends on the executive remaining employed through the applicable vesting date.
Varex Imaging Corp executive Mark S. Jonaitis, SVP and GM, X-Ray Sources, reported equity compensation activity dated December 10, 2025. Two restricted stock unit awards converted into a total of 12,599 shares of common stock, increasing his direct holdings before tax withholding. To satisfy associated tax obligations, 5,526 shares were withheld at a price of $11.70 per share, leaving him with 77,341 shares of common stock owned directly.
He also received a new grant of 26,041 restricted stock units, each convertible into one share of common stock. This grant is scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029, while earlier RSU grants include vesting through December 10, 2027.
Varex Imaging Corp executive Andrew Hartmann, SVP and GM, Detectors, reported equity award transactions in the company’s common stock. On 12/10/2025, restricted stock units vested and converted into 4,664 and 7,935 shares of common stock, with each unit converting one-for-one into a share. To satisfy tax withholding from this vesting, 3,636 shares were withheld at a price of $11.7 per share. After these transactions, he directly owned 36,182 common shares.
Hartmann also continues to hold stock-based incentives through restricted stock units. Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest on December 10, 2027, and he held 7,936 restricted stock units following the reported transactions. In addition, he received a new grant of 26,041 restricted stock units on December 10, 2025, and held 26,401 restricted stock units afterward, scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029, with shares delivered on each vesting date.
Varex Imaging Corp President and CEO, who is also a director, reported equity award activity in company stock dated 12/10/2025. Previously granted restricted stock units (RSUs) converted into 26,652 and 47,613 shares of common stock as they vested, and 32,566 shares were withheld at a price of $11.7 to satisfy tax withholding obligations related to this vesting. After these transactions, the reporting person directly holds 231,892 shares of common stock.
On the same date, the officer received a new grant of 156,250 RSUs, which are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Earlier RSU grants from December 10, 2021 and December 10, 2023 have already partially vested, with remaining portions scheduled to vest on December 10, 2027. Each RSU converts into one share of common stock upon vesting and delivery.
Varex Imaging Corp reported that its Chief Legal Officer received an equity award of 17,094 restricted stock units, each converting into one share of common stock. The award is reported as a Form 4 transaction dated December 10, 2025.
These restricted stock units are scheduled to vest in two equal installments, with 50% vesting on December 10, 2027 and the remaining 50% on December 10, 2029. On each vesting date, the underlying common shares will be delivered to the officer, providing long-term stock-based compensation tied to the company’s future performance.
Varex Imaging Corp’s chief human resources officer, Karen L. Aranki, reported equity award activity dated December 10, 2025. She acquired 6,665 shares of common stock upon the vesting of restricted stock units, which convert into common stock on a one-for-one basis. To cover tax withholding arising from this vesting, 1,923 shares were withheld and disposed of at a price of $11.7 per share, leaving her with 4,919 shares of common stock held directly afterward.
On the derivative side, 6,665 restricted stock units were settled into common stock, and she retained 6,666 restricted stock units from a grant originally made on December 10, 2023, which is scheduled to vest further on December 10, 2027. She also received a new grant of 21,875 restricted stock units on December 10, 2025, set to vest 50% on December 10, 2027 and 50% on December 10, 2029, with vested shares to be delivered on each vesting date.
Varex Imaging Corp's Chief Financial Officer reported multiple equity transactions in company stock. On 12/10/2025, restricted stock units converted into 7,063 and 13,966 shares of common stock, consistent with the one-for-one RSU terms. To cover tax obligations, 5,227 shares were disposed of at $11.7 per share, leaving 106,891 shares of common stock directly owned.
The report also shows a new grant of 58,333 restricted stock units, scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029, along with earlier RSU awards that continue to vest on their original schedules.
Insider sale by Varex Imaging Corp officer under a pre-established plan. Karen L. Aranki, Chief Human Resources Officer and a company officer, reported the sale of 3,174 shares of Varex Imaging common stock on 09/19/2025 at an average price of $12.34 per share. After the transaction she beneficially owned 177 shares. The filing states the sales were effected pursuant to a 10b5-1 trading plan adopted June 17, 2025, indicating these trades followed an established written arrangement rather than ad hoc decisions. The Form 4 is signed and dated 09/22/2025.